Overprescription of short-acting β<sub>2</sub>-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) study
Ashraf Al Zaabi(Zayed Military Hospital), Maarten Beekman(The Netherlands Cancer Institute), Saleh Al Mutairy(Adan Hospital), Siraj Wali(King Abdulaziz University), Arzu Yorgancıoğlu(Manisa Celal Bayar University), Hamdan Al‐Jahdali(King Saud University), Kurtuluş Aksu(Ankara Spine Center), Mohamed Elsayed, Nasser Al Busaidi(University of Alberta)
Cited by 15
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
|Journal of Allergy and Clinical Immunology|2012|642
Role of Transforming Growth Factor–β in Airway Remodeling in Asthma
|American Journal of Respiratory Cell and Molecular Biology|2010|420
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
|New England Journal of Medicine|2018|392
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
|The Lancet Respiratory Medicine|2021|297